<SEC-DOCUMENT>0001193125-23-070187.txt : 20230314
<SEC-HEADER>0001193125-23-070187.hdr.sgml : 20230314
<ACCEPTANCE-DATETIME>20230314163201
ACCESSION NUMBER:		0001193125-23-070187
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20230314
DATE AS OF CHANGE:		20230314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Archer-Daniels-Midland Co
		CENTRAL INDEX KEY:			0000007084
		STANDARD INDUSTRIAL CLASSIFICATION:	FATS & OILS [2070]
		IRS NUMBER:				410129150
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00044
		FILM NUMBER:		23731495

	BUSINESS ADDRESS:	
		STREET 1:		77 W. WACKER DR.
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601
		BUSINESS PHONE:		312-634-8233

	MAIL ADDRESS:	
		STREET 1:		77 W. WACKER DR.
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARCHER DANIELS MIDLAND CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d486939ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Proxy
Statement Pursuant to Section&nbsp;14(a) of the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp; <U></U>) </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant &#9745; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant &#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2)) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9745;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">ARCHER-DANIELS-MIDLAND COMPANY </P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Name of Registrant as Specified In Its Charter) </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Name of Person(s) Filing Proxy
Statement, if other than the Registrant) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9745;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g486939g0314025731148.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ADM Board of Directors Enhances R&amp;D, Innovation Expertise with Nomination of Elanco Executive Ellen de Brabander</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CHICAGO, March&nbsp;14, 2023&#151;ADM (NYSE: ADM), a global leader in human and animal
nutrition, today announced that its Board of Directors has nominated Elanco executive vice president for Innovation and Regulatory Affairs, Dr.&nbsp;Ellen de Brabander, to stand for election to the Board at the company&#146;s upcoming Annual
Stockholders&#146; Meeting on May&nbsp;4, 2023.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Our Board&#146;s leadership
has been critical to our portfolio transformation, and with the addition of Ellen de Brabander we&#146;re adding new expertise to help power our growth,&#148; said Chairman and CEO Juan Luciano. &#147;Ellen brings a broad scientific background and
deep R&amp;D and innovation experience in human nutrition, life sciences and animal health &#150; which align well with many of the growth opportunities ADM is pursuing.&#148;</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In her current role at Elanco, de Brabander drives early and late-stage pipeline
execution across pet health and farm animals, including nutritional health solutions. She previously served as senior vice president for R&amp;D at PepsiCo, with company-wide responsibility for food safety, quality, regulatory, and digital
transformation in R&amp;D, and before that, for all product innovations for the nutrition category. De Brabander has also held executive leadership positions in Boehringer Ingelheim (then known as Merial), Merck Animal Health (previously Intervet),
and DSM. De Brabander holds a Ph.D. in <FONT STYLE="white-space:nowrap">bio-organic</FONT> chemistry from Leiden University in The Netherlands, having completed post-doctoral work in molecular biology at the Massachusetts Institute of Technology.
She has <FONT STYLE="white-space:nowrap">co-authored</FONT> more than 60 publications in scientific journals, holds 18 patents, and has received multiple awards for her research, including the Golden Medal from the Royal Dutch Chemical Society in
2000 for Best Chemist under 40. She was a founding board member of the European Institute of Technology and founding CEO of EIT Food, the largest public-private partnership in the food sector.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ADM also announced that Lead Director Donald Felsinger will retire from the Board,
having reached the retirement age of 75.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;When Don Felsinger joined our Board
of Directors in 2009, ADM was a very different company,&#148; Luciano said. &#147;Over the last decade and more, we&#146;ve built a better ADM, and Don&#146;s leadership and guidance have been integral to that process of strategic realignment and
growth. Our entire company owes him thanks for his invaluable service.&#148;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Francisco Sanchez, a member of the Board since 2014, also has determined not to stand for
<FONT STYLE="white-space:nowrap">re-election.</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g486939page2.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;At a time of increasing global complexity, Francisco brought to our Board important experience and expertise in public policy, global
trade and international investment,&#148; Luciano said. &#147;As we made decisions around investments in key growth regions around the world, we knew we could count on Francisco&#146;s expertise to help guide us. We appreciate his service to ADM,
and wish him all the best.&#148;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ADM</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ADM unlocks the power of nature to enrich the quality of life. We&#146;re a premier
global human and animal nutrition company, delivering solutions today with an eye to the future. We&#146;re blazing new trails in health and well-being as our scientists develop groundbreaking products to support healthier living. We&#146;re a
cutting-edge innovator leading the way to a new future of plant-based consumer and industrial solutions to replace petroleum-based products. We&#146;re an unmatched agricultural supply chain manager and processor, providing food security by
connecting local needs with global capabilities. And we&#146;re a leader in sustainability, scaling across entire value chains to help decarbonize our industry and safeguard our planet. From the seed of the idea to the outcome of the solution, we
give customers an edge in solving the nutritional and sustainability challenges of today and tomorrow. Learn more at <U>www.adm.com</U>.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ADM Media Relations</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jackie Anderson</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">media@adm.com</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">312-634-8484</FONT></FONT></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Source: Corporate Release</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Source: ADM</I></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g486939page2.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g486939g0314025731148.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g486939g0314025731148.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" != 'T# 2(  A$! Q$!_\0
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M/L[26YEM;<1Q(6;]VO:K6!:^T8SRZ5KN1XFTLH_C;\Z[GX;QW3RWEPTK_9@
MFTG@OUS^ _G7%7L[7E[+,553(Y.U1P,]A7L/AS3!I.AV]L1B3;OD_P!X\G\N
MGX486-YW[')E])SK\W2)JT445Z1]"%%%% !7-^*]1,4*V4;89QN?'IV%=&2
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MJXN;C#N#U4=A_GUKH:UPU/DAKNS3 T/94M=WJ%%%%;G8%%%% &7K]W]ETJ0
MX>7Y!_7]*X!JZ3Q7.[WJ0XPB+Q[D]?Z?E7.,#7RV95O:8AKHM#"H[LUM%T(Z
M@1/.WEVX/KRWTKM+:"ULXA%;K'&@[ ]?K7F1+>M1DMZUKA<9"A'2&O>__ (5
M10Z'J_F)_?7\Z/,3^^OYUY(2WK43%O6NU9K?['X_\ 3Q5NAZQ/J5C;#,UW"G
ML7&?RKG-3\<6L"LEA&9I.@=QA1^'4_I7$K#/,<1QNY/91FM.S\):K>L"8/(0
M_P 4OR_IU_2G]<K5=*<3&6)JST@C'O[^ZU.Z::YD:21NF>@]A77>$_"15TU'
M48\$?-#"P_\ 'C_05MZ-X3L=**RO_I%P/XW'"_05OUO0PK3YZFX4,'[W/5U8
M4445WGHA1110 4$@#)X HKS'XT^(GTSP[!I5M*4GOW/F;3@^4O4?B2!^=7"#
MG)10F[*YZ(;VP;[UU;'ZR+4R+#(@=!&RGD$ $&OC/)KZ"^"FO?VAX7FTJ5\S
M6$GR@GGRWR1^1W?I6U7#*$>:]R8SN['I?EQ_W%_*J_VO3O\ GXM?^^UJ:Y_X
M]9O]P_RKXU;[Q^M11H*I<)2L?8GVO3O^?BU_[[6IU2%U#*L;*>A !%?&WER;
M-^QMOKCBM#2_$.KZ),LNFZC<6S#LCG:?J.A_&MW@ET9//Y'UX%51A0!]!0S*
MBEG8*H&22< 5YW\.?B6GBH_V9J2I#JJ+N4KPLX'4@=F'<?B*UOB???8?AYJK
M9PTJ+"/^!, ?TS7-[-J?(S2ZM<Z;^T++_G\M_P#OZ/\ &K (90RD$$9!'>OC
M#)]:^B_@]XD_MCPG_9\SYNM-(CY/)C/W#^'(_ 5K5P_)'F3N3&=W8]%JO_:%
ME_S]P?\ ?P?XUR7Q0\3?\(YX/F$+[;R]S;PX/(R/F;\!^I%?,N3ZT4</[2-V
M[!*=F?9_6F1RQR@F.1' ."5;.#7G7PQNKG7OAC+9FY8SQ/);*[$Y48! )ZXP
MV/I5S0_"&K6D4RO=?8<OD&%]Q8>AZ#:O0=^>:S=-)M-[%7.\KY>^)FO?V_XW
MO9$?=;VQ^S0\\87J?Q;)KW_QQKH\.>#]0OU;;,(_+@_ZZ-P/RZ_A7REDLV2<
MDFNC"0WD14?0UV\/7:^$D\0D'[,UV;4#'?;G=].H_"MSX6Z]_8?CBT\Q]MO>
M?Z-+D\?-]T_]]8_6O3)K;PV?A/\ \(V-9TPW"VN\?Z2G^O\ O^O][CZ5X K,
MCAE)#*<@CM6\9>UC),AKE:/LJY_X]9O]P_RKXU;[Q^M?5WA?7!XB\%6NI;@9
M)+<K+CM(HPWZC]:^46^\?K66$33DF54Z'U!\-8HW^'.CAXU8&)LY7.?G:N/^
M+O@33TT9_$.F6R6\\##[0D2A5D4G&[ [@D?7-=G\,_\ DG.C?]<F_P#0VIGQ
M/NX;3X>:J96 \U%B0'NQ8?\ US^%81DU6T[E->Z?-.EZC/I.JVNH6S%9K>59
M%(/H>GXU[=\:M563P7I<<1^6]G64>ZA"?YL*\&[UZ7\6[ADC\,Z8Y.^VTU&<
M>C, /_9*[*D4ZD69IZ,\TKKOAOXC/AOQE:S2/MM;@_9[C)XVL>#^!P?SK3^$
M_ARV\1ZGJ]M>+F$V#1YQDHS,N&'N,$UQ>KZ7<Z+JUUIMVNV>WD*-[^A'L1R/
MK5MQFW!BU6IU7Q3\3?\ "1>+YDAD#6=CF"'!X8C[S?B?T KB*L6-E<:E?P65
MK&9+B>01QJ.Y)Q7>_%+PQ!X7@\/6EN 0MHT<C@??<-EF/U+?E0G&%H(-7J=3
M\!;S-EK-D3]R2.8#Z@@_^@BO8J^?O@=>^3XON[4GBXM&Q]58'^6:^@:\_$JU
M1FT-CP[XYZ]YU_8Z%$_RP+]HF _OMPH_ 9/_  *O+]*T74M<N6M],LYKJ9$W
MLL2Y(7.,_J*V?$R3:QXGU*_GF_>2W#\;<[0#@#KV  KUCX*:+!9:%?:@&WW$
M\_E$[<850#C\V/Z5U\RHTM#.W-(\E_X5[XN_Z %[_P!\5C:II&H:+="UU*TE
MM9RH<)(N"5/?]#7V'7DOQNT:&ZM-+U#=LG1V@)VYW*1D?D0?SJ*6)<I<K0Y0
MLC*^"FO8@U7097^]&;F $]\8<?\ H)_ UX^WWC]:ZWP<)M'\7:7>0S9(N%C9
M2O#*QVL.OH35_P ?>!K;PYK[1VETQ@GS(D;1\Q@G[N<\UJN6-1^9+NT;WACX
MOV7AWPI8Z4=*N)YK9"I?S JL2Q/H3WKCO&?CS4_&=Q']I5;>TB.8K:,D@'U)
M[GWK(&D98#S^IQ]S_P"O7I_A+X/:?J4$=]J&I32Q=?(BC"9^K9/\A2:I4WSO
M<?O/0X[X<^#Y_%7B.$O$?[.M7$ES(1P0.0GU/\LU+\6;T7GQ#U!1]VW5(1^"
M@G]2:^C],TNQT:QCLM.MH[>WC^ZB#]3ZGW-?,/B6T>^\4:K<R3?-)=RD_+_M
M'WJ*53VE1RZ(<HV5CTCX#686PUB](^_+'$#] 2?_ $(4?&OPF9[>'Q):1$R1
M 1784=5_A?\ #H?J/2NB^#UDEGX'!4Y:6YD=CC'H/Z5WQ (((!!Z@USSJN-9
MR125XV/%?@IX2+2R^);R(A4S%:!AU/\ $X_#@?4UH_'BVW:'I-T!_J[AHR?]
MY<_^RUZRJA5"J  .@ Z5P?Q?M%N_ CAC@QW,;*<9YY']:<:KE64F#C:-CQSX
M77AL_B)I39PLKM$?^!*0/UQ7U!7REX?LWL_$>F7,<WSQW<3#Y?\ ;'O7U;58
'OXDQ4]C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g486939page2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g486939page2.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M_P#OF@!/[;O/^F?_ 'S0 ?VY>?\ 3/\ [YH /[<O/^F?_?- "?VY>?\ 3/\
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M#E#_ (7OK'_0(LO^^G_QH]DNX<H?\+WUC_H$67_?3_XT>R7<.4/^%[ZQ_P!
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MNZ_NK_WU0 ?V7=?W5_[ZH 3^RKK^ZO\ WU0 ?V5=?W5_[ZH /[*NO[J_]]4
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M_H#?^3,/_P 51]8I]PN@_P"%5^-/^@-_Y,P__%4?6*?<+HB?X4>-F8G^Q?\
MR:A_^+KGG5BW>X[H;_PJ?QM_T!/_ ":A_P#BZGVD>X70?\*G\;?] 3_R:A_^
M+H]I'N%T'_"I_&W_ $!/_)J'_P"+H]I'N%T'_"I_&W_0$_\ )J'_ .+H]I'N
M%T'_  J?QM_T!/\ R:A_^+H]I'N%T'_"I_&W_0$_\FH?_BZ/:1[A=!_PJ?QM
M_P! 3_R:A_\ BZ/:1[A=!_PJ?QM_T!/_ ":A_P#BZ/:1[A=!_P *G\;?] 3_
@ ,FH?_BZ/:1[A=!_PJ?QM_T!/_)J'_XNCVD>X71__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
